In addition to checkpoint proteins, coinhibitory ligands such as B7-H3 (also known as CD276) and B7X (also known as B7-H4) exhibit upregulated expression in many solid tumors, including CRC. This evidence concerns the gene VTCN1 and colorectal carcinoma.